Sivem-Losartan recall in Canada: impurity risk
In plain language
This recall involves Sivem-Losartan 25 mg, 50 mg, and 100 mg tablets sold in Canada. It's being recalled because an impurity was found above acceptable limits. Stop using the product and follow the return steps in the official notice.
What to do
- Stop using the product immediately.
- Check the lot numbers on your medication.
- Return the affected product to your pharmacy.
Get alerts for recalls like this
Get email alerts when new recalls affect products in this category.
Affected products
Sivem-Losartan 25 mg Tablet
Lot: 0050919, 0060919, 0070919, 0080919, 0080919A, 0101019, 0101019A, 0030120, 0040120, 0080620, 0090620
Sivem-Losartan 50 mg Tablet
Lot: 1121018, 1131018, 1130819, 1140819, 1150819, 1160819, 1170919, 1180919, 1070220, 1080220, 1090220, 1100220, 1110220, 1060220, 1120620
Sivem-Losartan 100 mg Tablet
Lot: 2070817, 2040218, 2101018, 2020219, 2030219, 2040219, 2090619, 2100919, 2110919, 2120919, 2130919, 2140919, 2151119, 2050420, 2060420
Why this matters
Presence of impurity above acceptable concentration limit
Do I have this product?
This recall only applies to specific products. Follow the steps below to check.
- 1
Check the product name
Make sure your product name matches one of the affected products listed above.
- 2
Check the lot number
Lot numbers identify specific production batches.
Affected lots: 0050919, 0060919, 0070919, 0080919, 0080919A, 0101019, 0101019A, 0030120, 0040120, 0080620, 0090620, 1121018, 1131018, 1130819, 1140819, 1150819, 1160819, 1170919, 1180919, 1070220, 1080220, 1090220, 1100220, 1110220, 1060220, 1120620, 2070817, 2040218, 2101018, 2020219, 2030219, 2040219, 2090619, 2100919, 2110919, 2120919, 2130919, 2140919, 2151119, 2050420, 2060420
If your product matches one or more of the details above, it may be affected by this recall.
If your product does not match these details, it is not affected by this recall.
When in doubt, always check the official notice.
Frequently Asked Questions
Why was this product recalled?
Presence of impurity above acceptable concentration limit
What should consumers do?
Stop using the product immediately. Check the lot numbers on your medication. Return the affected product to your pharmacy.
Where was the product sold?
This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.
Is there a health risk?
Yes, there may be a health risk. Presence of impurity above acceptable concentration limit
When was this product recalled?
This product was recalled on May 26, 2021.
Is the Sivem-Losartan brand affected by this recall?
Yes, Sivem-Losartan products are affected by this recall. This recall involves Sivem-Losartan 25 mg, 50 mg, and 100 mg tablets sold in Canada. It's being recalled because an impurity was found above acceptable limits. Stop using the product and follow the return steps in the official notice.